NephrologyRheumatology

KRYSTEXXA

KRYSTEXXA (pegloticase) is a recombinent porcine-like uricase used to treat chronic gout.
Infusion or injection therapy referral
What it treats Chronic Gout
Prescribed by Rheumatologists & Nephrologists
How it’s administered Intravenous (IV) infusion
Frequency Every two weeks for as long as your doctor recommends
Length of treatment Over an hour

About This Therapy

KRYSTEXXA (pegloticase) is a recombinent porcine-like uricase used to treat chronic gout. Gout is a kind of arthritis caused when there is too much uric acid in the body. KRYSTEXXA metabolises (converts) uric acid to a water-soluble compound called allantoin, which your body can eliminate easily. KRYSTEXXA can lower uric acid levels very quickly, and dissolve gout build-up over time.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

KRYSTEXXA REFERRAL FORM

KRYSTEXXA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for KRYSTEXXA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.